Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world study

Outcomes of first-line anti-PD-L1 blockades combined with brain radiotherapy for extensive-stage small-cell lung cancer with brain metastasis

(2022) Ji Ma et al.   JOURNAL OF NEURO-ONCOLOGY

1533P Atezolizumab (ATZ) plus carboplatin (Cb) and etoposide (eto) in patients with untreated extensive-stage small cell lung cancer (ES-SCLC): Results from the interim analysis of MAURIS trial

(2022) E. Bria et al.   ANNALS OF ONCOLOGY

LBA54 Three years survival outcome and continued cemiplimab (CEMI) beyond progression with the addition of chemotherapy (chemo) for patients (pts) with advanced non-small cell lung cancer (NSCLC): The EMPOWER-Lung 1 trial

(2022) M. Özgüroğlu et al.   ANNALS OF ONCOLOGY

1539P Real-world (RW) outcomes of second-line (2L) small cell lung cancer (SCLC) patients treated with lurbinectedin

(2022) A. Estrin et al.   ANNALS OF ONCOLOGY

1532P Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Preliminary efficacy results

(2022) D. Isla et al.   ANNALS OF ONCOLOGY

Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer

(2022) Rebekah Rittberg et al.   Frontiers in Oncology

Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)

(2021) Stephen V. Liu et al.   JOURNAL OF CLINICAL ONCOLOGY

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

(2021) A.-M.C. Dingemans et al.   ANNALS OF ONCOLOGY

Survival and pretreatment prognostic factors for extensive‐stage small cell lung cancer: A comprehensive analysis of 358 patients

(2021) Li‐Ling Huang et al.   Thoracic Cancer

Role of Prophylactic Cranial Irradiation in Extensive-Stage Small Cell Lung Cancer

(2021) Nathan Y. Yu et al.   Journal of the National Comprehensive Cancer Network

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer

(2021) O. Molinier et al.   ESMO Open

Treatment patterns and survival outcomes for small-cell lung cancer patients – a Swedish single center cohort study

(2020) Salomon Tendler et al.   ACTA ONCOLOGICA

The use of radiation therapy for oligoprogressive/oligopersistent oncogene-driven non small cell lung cancer: State of the art

(2020) D. Franceschini et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial

(2020) Nathalie Baize et al.   LANCET ONCOLOGY

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

(2020) Jonathan W Goldman et al.   LANCET ONCOLOGY

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

(2018) Leora Horn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial

(2017) Ben J. Slotman et al.   LUNG CANCER

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

(2016) Andrew G. Nicholson et al.   Journal of Thoracic Oncology

Characteristics, treatment patterns and outcomes of patients with small cell lung cancer—A retrospective single institution analysis

(2010) Andreas Hermes et al.   LUNG CANCER